AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05411146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]-etrumadenant
Description: Administered as specified in the treatment arm.
Study NCT05700227 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Daily Adaptive External Beam Radiation Therapy
Description: Daily adaptive external beam radiation therapy delivered on Varian Ethos treatment system.
Study NCT04759807 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: The placebo designed for administration in the proposed clinical study consists of a dry powder composed of the same excipients as the active (sodium sulfate, mannitol and polysorbate 80), pre-metered into HPMC capsules at the same 5 mg powder fill weight as the active formulations. Subjects will receive 14 doses administered once daily in the morning.
Study NCT04759807 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PUR1800 250 ug
Description: The PUR1800 drug product intended for use in the proposed clinical study comprises bulk powder containing 5 wt% or 10 wt% RV1162 pre-metered into HPMC capsules for oral delivery via a passive DPI. The capsules contain 5 milligrams (mg) of the powder formulation, corresponding to a 250 μg nominal dose strength of RV1162. Subjects will receive 14 doses administered once daily in the morning.
Study NCT04759807 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PUR1800 500 ug
Description: The PUR1800 drug product intended for use in the proposed clinical study comprises bulk powder containing 5 wt% or 10 wt% RV1162 pre-metered into HPMC capsules for oral delivery via a passive DPI. The capsules contain 5 milligrams (mg) of the powder formulation, corresponding to a 500 μg nominal dose strength of RV1162. Subjects will receive 14 doses administered once daily in the morning.
Study NCT06169488 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar Interbody Fusion
Description: Fusion of one or two lumbar levels with either a transforaminal lumbar interbody fusion (TLIF) or an anterior lumbar interbody fusion (ALIF) procedure.
Study NCT06169488 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Multidisciplinary rehabilitation
Description: Outpatient multidisciplinary rehabilitation based on the treatment model described by Brox et al and Hellum et al consisting of a cognitive approach and supervised physical and functional training.
Study NCT05229250 — intervention group
Intervention type: OTHER
Intervention: Cycling test
Description: RAMP and MULTI-STAGE test
Study NCT05229250 — intervention group
Intervention type: OTHER
Intervention: Occlusion tests
Description: Occlusion test before and after exercise
Study NCT05229250 — intervention group
Intervention type: DEVICE
Intervention: NIRS during cycling
Description: NIRS devices measuring oxygenation during exercise
Study NCT05229250 — intervention group
Intervention type: DEVICE
Intervention: CPET
Description: Cardiopulmonary exercise testing (heart rate, pulmonary gas exchange) during exercise
Study NCT05229250 — intervention group
Intervention type: DEVICE
Intervention: Echo-Doppler examination
Description: Peak systolic velocity and vascular stiffness measurements in the iliac-aortic tract
Study NCT06112028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tongxinluo capsule
Description: On the basis of conventional treatment, the study participants in the experimental group were given Tongxinluo capsule for 12 months.
Study NCT06112028 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Primary therapy
Description: Routine oral aspirin enteric-coated tablets, clopidogrel bisulfate tablets and rosuvastatin calcium tablets (or atorvastatin calcium tablets)
Study NCT06112028 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Primary therapy
Description: Routine oral aspirin enteric-coated tablets, clopidogrel bisulfate tablets and rosuvastatin calcium tablets (or atorvastatin calcium tablets)
Study NCT05102110 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Oricol Test
Description: Assessment of rectal mucus for material from aero-digestive cancers.
Study NCT06320314 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tested product (2039125 03)
Description: application twice a day of the tested product (in the morning and evening) and a sunscreen (in the morning and at midday) to the face for 3 months
Study NCT06372600 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma
Description: Autologous Platelet-rich plasma injection was performed under ultrasound guidance
Study NCT05497167 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Period Kit
Description: This is a single arm interventional study wherein the subjects enrolled will all participate in the study in the same way by being asked to answer pre-study survey questions concerning their attitudes towards menarche, receiving a period kit to explore on their own for two weeks, and then being asked to answer post-study survey questions.
Study NCT04780178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults with Alzheimer's Disease and Related Dementias
Description: A telephone-based acceptance and commitment therapy for caregivers
Study NCT06013098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 30%Oxygen
Description: 60%FiO2 in one lung ventilation and 30% FIO2 in both lungs ventilation
Study NCT06013098 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 60%Oxygen
Description: 100%FiO2 in one lung ventilation and 60% FIO2 in both lungs ventilation
Study NCT04793594 — intervention group
Intervention type: OTHER
Intervention: Berg Balance Test
Description: Patients evaluate with Berg Balance Test for balance
Study NCT04793594 — intervention group
Intervention type: OTHER
Intervention: Tinetti Balance And Gait Test
Description: Patients evaluate with Tinetti Balance And Gait Test for balance
Study NCT04793594 — intervention group
Intervention type: OTHER
Intervention: Time Up And Go Test
Description: Patients evaluate with Time Up And Go Test for balance
Study NCT05272202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: STIM-MOTANA is an interventional and prospective study conducted in patients scheduled for surgery under general anesthesia, involving EEG measurements and median nerve stimulation. In this study, 30 patients will undergo surgery under total intravenous anesthesia using a propofol target-controlled infusion pump. The rest of the anesthetic protocol will be at the discretion of the anesthesiologist in charge. After surgery, patients will have a gradual decrease of propofol at different effect-site concentrations (from 4.0 μg/ml to 2.0 μg/ml, in increments of 0.5 μg/ml).
Study NCT05272202 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Median nerve stimulation
Description: The right-hand median nerve will be stimulated in the same way as for measurement with a conduction velocity or for an evoked potential. Two stimulation electrodes will be placed on the right-hand wrist according to the standards.The stimulation is transcutaneous and painless using the specific Micromed device Sd Ltm Stim Energy (Micromed, Mˆacon, France). The stimulus intensity will range between 3 and 14 mA. The stimulation duration will be 100 ms with a frequency of 0.1 Hz.
Study NCT05272202 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EEG measurements
Description: Changes in ERD and ERS patterns during median nerve stimulation according to the various propofol concentrations will be continuously monitored by an EEG amplifier. EEG signals will be acquired using the OpenViBE platform with a Biosemi Active Two 64-channel EEG system, arranged in the Biosemi's ABC system covering the entire scalp at 2048 Hz. Among all recorded sites, some of the electrodes will be localized around the primary motor cortex, the motor cortex, the somatosensory cortex, and the occipital cortex.
Study NCT04081818 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nutritious Mushrooms
Description: The Intervention group will consume antioxidant rich and Vitamin D2-enhanced mushrooms as a snack daily for 3 months.
Study NCT05123118 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated intervention of smoking cessation and breastfeeding
Description: The intervention group will receive an integrated intervention of smoking cessation and breastfeeding: education and counseling, monitoring and feedback, and contingent financial incentives.
Study NCT05608265 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OSNAT 800 IO
Description: Real-time, combined scanning laser ophthalmoscope (SLO) and optical coherence tomography (OCT) for retinal imaging
Study NCT05191485 — intervention group
Intervention type: OTHER
Intervention: Qualitative interviews
Description: We will conduct semi-structured interviews with target patients, patients' representatives and other stakeholders to assess their decisional needs. The cognitive debriefing interview will start afterwards, and participants will answer probing questions asked by interviewers about DA_LCMT 1.0. Then the field testing interviews will conducted one-on-one structured interviews.
Study NCT05123118 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention placebo control
Description: Participants in the control group will receive usual prenatal care from physicians, nurses, or social workers. They will receive best standard care on smoking cessation and breastfeeding, including referral to the New York State Smokers' Quitline and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).
Study NCT05348382 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intradermal acupuncture
Description: In addition to basis standard pharmacological treatments, intradermal needles will be inserted in each selected acupoint and retained in place for 48 hours. Points around the herpes zoster sites (about 1 cm peripherally) are selected for intradermal acupuncture (IDA) encircled needling. Meanwhile, intradermal acupuncture is also performed in Ashi acupoints in the distribution area of herpes zoster. The operator will tear off the adhesive tape of intradermal needles and stick them on the selected acupoints, and then apply pressure on intradermal needles over the selected acupoints perpendicularly according to the patient's tolerance. In addition, patients will be instructed to press the intradermal needles 4 times per 24 hours throughout the needle retention period, with the aim to increase stimulation for treatment enhancement, each time lasting around 30 seconds.
Study NCT05348382 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham intradermal acupuncture
Description: In addition to basis standard pharmacological treatments, sham intradermal acupuncture will be implemented in the same acupoints as the intradermal acupuncture group using pseudo-intradermal needling. Additionally, participants in the sham intradermal acupuncture group will be treated in another room to avoid direct communications with subjects in the IDA group.
Study NCT05442164 — intervention group
Intervention type: BEHAVIORAL
Intervention: DANAKIR support network
Description: The DANAKIR intervention will consist of:~* Structured written discharge information~* Invitation to the DANAKIR monthly information meeting DANAKIR meetings The monthly meetings are a core component of the support network. One time each month, a meeting will be held at Herlev Hospital with the participation of an emergency surgeon, an emergency surgery dedicated nurse, a dietician, and a physiotherapist. Each professional (surgeon, nurse, dietician, physiotherapist) will host an informative 15 minute session regarding the postoperative course after major emergency surgery. Following the presentations time for questions in plenum and private with the different experts will be held. Furthermore, there will be an opportunity for networking at the DANAKIR meeting. Each meeting is planned to last 2 hours. At the end of each meeting the patients will be asked to evaluate the meeting and content.
Study NCT05463185 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching exercises
Description: Stretching exercises along with manual lymphatic drainage
Study NCT05463185 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Soft tissue mobilization
Description: Soft tissue mobilization along with manual lymphatic drainage
Study NCT05231590 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
Description: SARS-CoV-2 recombinant spike protein (12.5 µg) with Advax-SM adjuvant (7.5 mg) in two doses with a 21-day interval administered with intramuscular injections in the non-dominant arm
Study NCT05231590 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
Description: SARS-CoV-2 recombinant spike protein (25 µg) with Advax-SM adjuvant (15 mg) in two doses with a 21-day interval administered with intramuscular injections in the non-dominant arm
Study NCT05160688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency management
Description: Participants will be paid to abstain from cannabis use.
Study NCT06602206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Treatment
Description: Hot pack,TENS, ultrasound and exercises
Study NCT06602206 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Treatment
Description: Hot pack,TENS, ultrasound and exercises
Study NCT06602206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: shoulder mobilization
Description: In the glenohumeral joint mobilization technique, distraction, anterior-posterior gliding, and inferior gliding movements will be applied.
Study NCT06602206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: neck mobilization
Description: Bridge, lateral flexion movement combined with traction, anterior-posterior gliding with traction, and lateral gliding techniques will be applied in neck mobilization.
Study NCT05048121 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cosmetic Active Ingredient CLS02021
Description: Topical, face application of the cream base with the CLS02021, two times a day in a period of 30 days
Study NCT05048121 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo PLC01021
Description: Topical, face application of the cream base, two times a day in a period of 30 days
Study NCT06307574 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: bpMedManage
Description: In this 16-week RCT, a total of 100 older adults with MCI will be recruited. There are two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on the education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.
Study NCT06307574 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: bpMedManage
Description: In this 16-week RCT, a total of 100 older adults with MCI will be recruited. There are two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on the education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.
Study NCT05330195 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bicycle Ergometer Training
Description: Bicycle ergometer training will be performed 3 days a week for 12 weeks at 60% of their maximum hearth rate with 40 minutes total duration consisting of 5 min warm up and 5 min cool down period to children in treatment group.
Study NCT05330195 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home-based exercise group
Description: Children will be given a home program including stretching, breathing, normal joint movement, body weight and mildly resistant exercises, and children will be asked to do these for 3 to 5 days a week.
Study NCT05330195 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based exercise group
Description: Children will be given a home program including stretching, breathing, normal joint movement, body weight and mildly resistant exercises, and children will be asked to do these for 3 to 5 days a week.
Study NCT05746026 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psycho-educational Program
Description: This program consisted of five (5) sessions during two weeks.~* Session 1: introduction and basic information about Climate Change~* Session 2: causes and factors that contribute to climate change by humans and nature~* Session 3: explain climate change risks, describe and explain the impact of climate change on elder health and well-being.~* Session 4: teaching proper behaviors that contribute the most to climate-driving emissions.~* Session 5: learning how adapting and coping with climate change. Adaptation includes a range of coping actions that individuals may take, as well as psychological processes (e.g. emotion management, problem solving, and cognitive reframing responses) that influence reactions to (and preparations for) adverse impacts of climate change, including chronic environmental conditions and extreme events.
Study NCT05746026 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psycho-educational Program
Description: This program consisted of five (5) sessions during two weeks.~* Session 1: introduction and basic information about Climate Change~* Session 2: causes and factors that contribute to climate change by humans and nature~* Session 3: explain climate change risks, describe and explain the impact of climate change on elder health and well-being.~* Session 4: teaching proper behaviors that contribute the most to climate-driving emissions.~* Session 5: learning how adapting and coping with climate change. Adaptation includes a range of coping actions that individuals may take, as well as psychological processes (e.g. emotion management, problem solving, and cognitive reframing responses) that influence reactions to (and preparations for) adverse impacts of climate change, including chronic environmental conditions and extreme events.
Study NCT05172648 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: oral spry
Description: Pour sterile distilled water into a 30ml small-capacity spray bottle and spray 4 times at the patient's mouth. They are on the tongue and under the tongue, the left side and the right side of the mouth. The same spray bottle is used by the same person. Consistent dosage and strength.
Study NCT05172648 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Cotton swab
Description: Moisten the mouth with sterile distilled water with an oral cotton swab.
Study NCT04851197 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flipped Learning Model
Description: Students in the intervention group will be given training on testicular cancer and testicular self-examination in accordance with the Flipped Learning Model. The students in the control group will receive the same training with the traditional method. It was aimed to examine the effect of the training given with the Flipped Learning Model on the students' knowledge levels and health beliefs about testicular cancer and self-testicular examination.
Study NCT04981236 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pericapsular nerve group block
Description: A curvilinear 2-5MHz ultrasound probe will be initially placed in a transverse plane over the anterior superior iliac spine and then aligned with the pubic ramus by rotating the probe counterclockwise approximately 45 degrees. In this view, the iliopubic eminence, the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle will be observed. A 22-gauge, 80-mm needle will be inserted from lateral to medial in an in-plane approach to place the tip in the musculofascial plane between the psoas tendon anteriorly and the pubic ramus posteriorly. A total volume of 20 ml of ropivacaine 0.3% will be injected.
Study NCT04981236 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periarticular block
Description: The periarticular injection solution contained 20mL of 7.5 mg/mL ropivacaine, 30mg of ketorolac, and 0.3mL of 1.0 mg/mL epinephrine. These agents were mixed with normal saline to a combined volume of 50mL. The surgeon injected this mixture into the tensor fascia lata, subcutaneous tissues, abductors, short external rotators muscles, and structures in the capsule.
Study NCT06145958 — intervention group
Intervention type: DRUG
Intervention: Luteinising Hormone-Releasing Factor Analogue
Description: Androgen Deprivation Therapy